New style

events
Conference
October 10, 2017
**Moscow, Russia October 10, 2017** – **InSysBio LLC**, one of the pioneers in Quantitative Systems Pharmacology (QSP) modeling and simulation for the drug development, announced a renewal of the corporate identity. >“Lately we have become more successful and have grown bigger. We are expanding our business and are attracting new customers and partners. And now we need to become more vivid and recognizable. That is why rebranding of the company is a logical step”, Oleg Demin Jr, the head of Business Development, spoke about the reasons for such changes. >“The official name InSysBio is now short and memorable. A new symbol is a cell made of gear-wheels. It shows that we consider the living organism and its processes as parts of the mechanism that is accurately described in our models and platforms. Corporate colors are just the employees’ favorite colors. It's so important to surround yourself with what you like and do what you love”, Oleg explained the meanings of attributes of the corporate identity. You can meet the new InSysBio in a week at the eighth American Conference on Pharmacometrics (ACoP8), to be held from October 15th to October 18th, 2017. The meeting will take place at the Marriott Resort: Harbor Beach Hotel, Fort Lauderdale, Florida. See InSysBio ACoP8 [Agenda here](http://insilicobio.ru/share/ACoP8_agenda.pdf). Don’t miss our exhibition **booth #4**.
October 2025
MoTuWeThFrSaSu
  
1
2
1. 02 Oct 2025 13:23 InSysBio to announce participation in BioTechX Europe 2025 with focus on AI and QSP InSysBio announces their participation in BioTechX Europe 2025. Oleg Demin, Chief Scientific Advisor and co-founder of InSysBio, and Igor Goryanin, Professor at University of Edinburgh, will host a roundtable discussion entitled, "Integrating Artificial Intelligence with Quantitative Systems Pharmacology (QSP): Opportunities and Challenges"
3
4
5
6
7
8
9
10
11
12
13
14
15
16
1. 16 Oct 2025 12:13 InSysBio to introduce a new data annotation service available in CYTOCON DB and fIVE DB InSysBio launches a new data annotation service designed to support researchers and analysts who require specific, literature-based biological data to be added to InSysBio’s CYTOCON or fIVE databases for use in QSP modeling, analysis, or decision-making. The new service allows clients to submit targeted data requests related to diseases, tissues, cell types, and cytokines
17
18
19
20
21
22
23
24
25
26
27
28
29
1. 29 Oct 2025 15:08 The project aims at mechanistic PK/RO modeling to predict optimal dose and regimen of BGB-B2033, GPC3 x 4-1BB bispecific antibody InSysBio, one of the world's pioneers of Quantitative Systems Pharmacology (QSP) modeling, announces its collaboration with BeOne Medicines, a global oncology company.
30
31
  
Upcoming Events
Tags
Latest News
29.10
InSysBio to announce its collaboration with BeOne Medicines
16.10
InSysBio to introduce a new data annotation service available in CYTOCON DB and fIVE DB
19.08
InSysBio to publish the new article "Revolutionizing drug discovery: Integrating artificial intelligence with quantitative systems pharmacology"
05.08
InSysBio to launch Immune Response Template Open for QSP modeling
25.06
InSysBio to announce extension of collaboration with discoveric bio alpha